+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Europe Diabetes Care Devices Market to 2027 - Regional Analysis and Forecasts by Product; End User; and Country

  • ID: 4801439
  • Report
  • Region: Europe
  • 149 pages
  • The Insight Partners
UP TO OFF
until Jan 15th 2020
1 of 3

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • BD
  • Dexcom, Inc.
  • Eli Lilly and Company
  • F. Hoffman-LA Roche Ltd.
  • Insulet Corporation
  • MORE
The Europe diabetes care devices market is expected to reach US$ 11,184.6 Mn in 2027 from US$ 6,853.3 Mn in 2018. The market is estimated to grow with a CAGR of 5.7% from 2019-2027.

The growth of the diabetes care devices market is primarily attributed to the rising incidence of diabetes and rising adoption of insulin injection pens over traditional syringes & vials. However, availability of alternatives for drug delivery and reuse of pen needles are likely to pose a negative impact on the market growth. On the other hand, increasing launch of GLP-1 analogues is likely to have a positive impact on the growth of the Europe diabetes care devices market in the coming years.

Glucagon like Peptide-1 also known as GLP-1 is a hormone produced in the gut that is released in response to the food consumed by an individual. The peptide reduces the appetite of an individual and helps to secrete insulin in the body among obese patients. In recent years, external injection of GLP-1 has been witnessing a significant traction due to increase in the number of doctor prescription for these hormones. The rising number of novel GLP-1 analogue launches is thus expected to indirectly provide opportunities for the manufacturers to develop therapy specific pen needles with incorporation of features such as bore size, length and material that is not reactive with the biologic.

In 2018, the glucose monitoring devices segment held a largest market share of 53.9% of the diabetes care devices market, by product. The glucose monitoring devices is expected to dominate its market share in 2027 owing to the rise in the prevalence of the diabetes and presence of the several market players that offers technically advanced products. The testing strips segment among the glucose monitoring devices is anticipated to witness the fastest growth rate of 6.6% during the forecast period, 2019 to 2027 owing to the enormous usages in the glucose monitoring devices.

In 2018, the homecare held a largest market share of 59.8% of the diabetes care devices market, by end user. This segment is also expected to dominate the market in 2027 owing to the rise in the demand for the glucose monitoring devices and insulin delivery devices. Increasing diabetic population, the ease of use, availability, and accessibility of insulin delivery devices has also increased the adoption of self-administration among patients is anticipated to grow at a steady rate during the forecast period. Also the homecare segment is also expected to grow at the fastest growth rate of 5.9% during the forecast period, 2019 to 2027.

Some of the major primary and secondary sources for diabetes care devices included in the report are, Centers for Diabetes and Endocrinology (CDE), Public Health England (PHE), Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA), International Diabetes Federation (IDF) and others.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • BD
  • Dexcom, Inc.
  • Eli Lilly and Company
  • F. Hoffman-LA Roche Ltd.
  • Insulet Corporation
  • MORE
Part 1. Introduction
1.1 Scope of the Study
1.2 Report Guidance

Part 2. Europe Diabetes Care Devices Market - Key Takeaways

Part 3. Europe Diabetes Care Devices Market - Market Landscape
3.1 overview
3.2 market segmentation
3.2.1 Europe Diabetes Care Devices Market - By Product
3.2.2 Europe Diabetes Care Devices Market - By End USer
3.2.3 Europe Diabetes Care Devices Market - By Country
3.3 PEST Analysis

Part 4. Europe Diabetes Care Devices Market - Key Market Dynamics
4.1 Key Market Drivers
4.1.1 Rising Incidence of Diabetes
4.1.2 Rising Adoption of Insulin Injection Pens Over Traditional Syringes and Vials
4.2 Key Market Restraints
4.2.1 Availability of Alternatives for Drug Delivery
4.2.2 Reuse of Pen Needles
4.3 Key Market Opportunities
4.3.1 Increasing Launch of GLP-1 Analogues
4.4 future Trends
4.4.1 Rapid Adoption of Safety Pen Needles Over Standard Pen Needles
4.5 Impact analysis

Part 5. Diabetes Care Devices Market - Europe Analysis
5.1 Europe DIABETES CARE DEVICES market Revenue Forecasts and Analysis
5.2 Market positioning
5.3 Performance OF KEY PLAYERS
5.3.1 Medtronic
5.3.2 F. Hoffmann-La Roche Ltd.

Part 6. Europe Diabetes Care Devices Market Analysis - By Product
6.1 overview
6.2 Europe diabetes care devices Market BY Product, 2018 & 2027 (%)
6.3 Europe DIABETES CARE DEVICES market Revenue And Forecasts to 2027, By Product (US$ Mn)
6.3.1 Europe Glucose Monitoring Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
6.3.2 Europe Insulin Delivery Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
6.4 Glucose Monitoring Devices Market
6.4.1 Overview
6.4.2 Europe Glucose Monitoring Devices Market Revenue and Forecast to 2027 (US$ Mn)
6.4.3 Glucometers Market
6.4.3.1 Overview
6.4.3.2 Europe Glucometers Market Revenue and Forecast to 2027 (US$ Mn)
6.4.4 Lancets Market
6.4.4.1 Overview
6.4.4.2 Europe Lancets Market Revenue and Forecast to 2027 (US$ Mn)
6.4.5 Testing Strips Market
6.4.5.1 Overview
6.4.5.2 Europe Testing Strips Market Revenue and Forecast to 2027 (US$ Mn)
6.4.6 Other Glucose Monitoring Devices Market
6.4.6.1 Overview
6.4.6.2 Europe Other Glucose Monitoring Devices Market Revenue and Forecast to 2027 (US$ Mn)
6.5 Insulin Delivery Devices Market
6.5.1 Overview
6.5.2 Europe Insulin Delivery Devices Market Revenue and Forecast to 2027 (US$ Mn)
6.5.3 Insulin Pens Market
6.5.3.1 Overview
6.5.3.2 Europe Insulin Pens Market Revenue and Forecast to 2027 (US$ Mn)
6.5.4 Insulin Syringes Market
6.5.4.1 Overview
6.5.4.2 Europe Insulin Syringes Market Revenue and Forecast to 2027 (US$ Mn)
6.5.5 Insulin Pumps Market
6.5.5.1 Overview
6.5.5.2 Europe Insulin Pumps Market Revenue and Forecast to 2027 (US$ Mn)
6.5.6 Other Insulin Delivery Devices Market
6.5.6.1 Overview
6.5.6.2 Europe Insulin Delivery Devices Market Revenue and Forecast to 2027 (US$ Mn)

Part 7. Europe Diabetes Care Devices Market Analysis - By End USer
7.1 Overview
7.2 Europe DIABETES CARE DEVICES MARKET, BY End USer, 2018 & 2027 (%)
7.3 Europe DIABETES CARE DEVICES market Revenue And Forecasts to 2027, By End USer (US$ Mn)
7.4 Homecare Market
7.4.1 Overview
7.4.2 Europe Homecare Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 hospitals & Clinics Market
7.5.1 Overview
7.5.2 Europe Hospitals & Clinics Market Revenue and Forecasts to 2027 (US$ Mn)

Part 8. Europe Diabetes Care Devices Market Revenue And Forecasts To 2027
8.1 Overview
8.2 Europe DIABETES CARE DEVICES market Revenue and Forecasts to 2027 (US$ Mn)
8.3 Europe DIABETES CARE DEVICES market Revenue And Forecasts to 2027, By Product (US$ Mn)
8.3.1 Europe Glucose Monitoring Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.3.2 Europe Insulin Delivery Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.4 Europe Insulin Delivery Devices market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.5 Europe DIABETES CARE DEVICES market Revenue And Forecasts to 2027, By End USer (US$ Mn)
8.6 Europe Diabetes care devices Market Revenue And Forecasts to 2027, By Country (%)
8.7 Germany DIABETES CARE DEVICES market Revenue and Forecasts to 2027 (US$ Mn)
8.7.1 Germany Diabetes Care Devices Market Revenue and Forecasts to 2027 (US$ Mn)
8.7.2 Germany Diabetes Care Devices Market Revenue And Forecasts to 2027, By Product (US$ Mn)
8.7.2.1 Germany Glucose Monitoring Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.7.2.2 Germany Insulin Delivery Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.7.3 Germany Diabetes Care Devices Market Revenue And Forecasts to 2027, By End USer (US$ Mn)
8.8 UK DIABETES CARE DEVICES market Revenue and Forecasts to 2027 (US$ Mn)
8.8.1 UK Diabetes Care Devices Market Revenue and Forecasts to 2027 (US$ Mn)
8.8.2 UK Diabetes Care Devices Market Revenue And Forecasts to 2027, By Product (US$ Mn)
8.8.2.1 UK Glucose Monitoring Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.8.2.2 UK Insulin Delivery Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.8.3 UK Diabetes Care Devices Market Revenue And Forecasts to 2027, By End USer (US$ Mn)
8.9 France DIABETES CARE DEVICES market Revenue and Forecasts to 2027 (US$ Mn)
8.9.1 France Diabetes Care Devices Market Revenue and Forecasts to 2027 (US$ Mn)
8.9.2 France Diabetes Care Devices Market Revenue And Forecasts to 2027, By Product (US$ Mn)
8.9.2.1 France Glucose Monitoring Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.9.2.2 France Insulin Delivery Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.9.3 France Diabetes Care Devices Market Revenue And Forecasts to 2027, By End USer (US$ Mn)
8.10 Spain DIABETES CARE DEVICES market Revenue and Forecasts to 2027 (US$ Mn)
8.10.1 Spain Diabetes Care Devices Market Revenue and Forecasts to 2027 (US$ Mn)
8.10.2 Spain Diabetes Care Devices Market Revenue And Forecasts to 2027, By Product (US$ Mn)
8.10.2.1 Spain Glucose Monitoring Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.10.2.2 Spain Insulin Delivery Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.10.3 Spain Diabetes Care Devices Market Revenue And Forecasts to 2027, By End USer (US$ Mn)
8.11 Italy DIABETES CARE DEVICES market Revenue and Forecasts to 2027 (US$ Mn)
8.11.1 Italy Diabetes Care Devices Market Revenue and Forecasts to 2027 (US$ Mn)
8.11.2 Italy Diabetes Care Devices Market Revenue And Forecasts to 2027, By Product (US$ Mn)
8.11.2.1 Italy Glucose Monitoring Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.11.2.2 Italy Insulin Delivery Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.11.3 Italy Diabetes Care Devices Market Revenue And Forecasts to 2027, By End USer (US$ Mn)

Part 9. Diabetes Care Devices Market - Industry Landscape
9.1 Overview
9.2 Comparative Company Analysis
9.3 Growth Strategies done by the companies in the Market, (%)
9.4 Organic Developments
9.4.1 Overview
9.5 Inorganic developments
9.5.1 Overview

Part 10. Diabetes Care Devices Market-Key Company Profiles
10.1 BD
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Financial Overview
10.1.4 Product Portfolio
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 novo nordisk a/s
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Financial Overview
10.2.4 Product Portfolio
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 B. Braun Melsungen AG
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Financial Overview
10.3.4 Product Portfolio
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 Medtronic
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Financial Information
10.4.4 Product Portfolio
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 Tandem Diabetes Care, Inc.
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Financial Information
10.5.4 Product Portfolio
10.5.5 SWOT Analysis
10.5.6 Key Developments
10.6 Insulet Corporation
10.6.1 Key Facts
10.6.2 Business Description
10.6.3 Financial Information
10.6.4 Product Portfolio
10.6.5 SWOT Analysis
10.6.6 Key Developments
10.7 Eli lilly and company
10.7.1 Key Facts
10.7.2 Business Description
10.7.3 Financial Overview
10.7.4 Product Portfolio
10.7.5 SWOT Analysis
10.7.6 Key Developments
10.8 Dexcom, Inc.
10.8.1 Key Facts
10.8.2 Business Description
10.8.3 Financial Overview
10.8.4 Product Portfolio
10.8.5 SWOT Analysis
10.8.6 Key Developments
10.9 Terumo Corporation
10.9.1 Key Facts
10.9.2 Business Description
10.9.3 Financial Overview
10.9.4 Product portfolio
10.9.5 SWOT ANALYSIS
10.9.6 KEY DEVELOPMENTS
10.10 F. Hoffmann-La Roche Ltd.
10.10.1 Key Facts
10.10.2 Business Description
10.10.3 Financial Overview
10.10.4 Product Portfolio
10.10.5 SWOT Analysis
10.10.6 Key Developments

Part 11. Appendix
11.1 About the Publisher
11.2 Glossary of Terms
11.3 Methodology
11.3.1 Coverage
11.3.2 Secondary Research
11.3.3 Primary Research
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • BD
  • Novo Nordisk A/S
  • B. Braun Melsungen AG
  • Insulet Corporation
  • Medtronic
  • Tandem Diabetes Care, Inc.
  • Eli Lilly and Company
  • Dexcom, Inc.
  • Terumo Corporation
  • F. Hoffman-LA Roche Ltd.
Note: Product cover images may vary from those shown
Adroll
adroll